Nawaf Alanazi (2022) “INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA”, Journal of Population Therapeutics and Clinical Pharmacology, 29(01), pp. 476–492. doi:10.53555/68zhqm37.